ADDIA

ADDIA cohort

ADDIA is a pioneering project aimed at revolutionizing Alzheimer’s disease (AD) diagnosis through the development and validation of a novel peripheral blood diagnostic biomarker kit. Spearheaded by Amoneta Diagnostics, ADDIA seeks to address the urgent need for fast, simple, and accurate diagnostic tools for AD.

LABORATORY PRIORITY SERVICES DELIVERED
WE HAVE GREAT SKILLS

5

Countries

13

Centers

221

Healthy Volontiers

450

AD Patients

195

NAD patients

ADDIA Sponsors